Practice Guideline
doi: 10.4158/EP151126.CS.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY
- PMID: 26731084
- DOI: 10.4158/EP151126.CS
Item in Clipboard
Practice Guideline
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY
Endocr Pract.
2016 Jan.
No abstract available
Comment in
-
Letter to the Editor.Endocr Pract. 2017 Jun;23(6):747-748. doi: 10.4158/1934-2403-23.6.747. Endocr Pract. 2017. PMID: 28614038 No abstract available.
Similar articles
-
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.Endocr Pract. 2015 Dec;21(12):1403-14. doi: 10.4158/EP151063.CS. Endocr Pract. 2015. PMID: 26642101
-
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.Endocr Pract. 2018 Jan;24(1):91-120. doi: 10.4158/CS-2017-0153. Epub 2018 Jan 17. Endocr Pract. 2018. PMID: 29368965 No abstract available.
-
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.Endocr Pract. 2017 Feb;23(2):207-238. doi: 10.4158/EP161682.CS. Epub 2017 Jan 17. Endocr Pract. 2017. PMID: 28095040 No abstract available.
-
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.Endocr Pract. 2013 May-Jun;19(3):536-57. doi: 10.4158/EP13176.CS. Endocr Pract. 2013. PMID: 23816937 Free PMC article. No abstract available.
-
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.Diabetologia. 2006 Aug;49(8):1711-21. doi: 10.1007/s00125-006-0316-2. Diabetologia. 2006. PMID: 16802130 No abstract available.
Cited by
-
The effect of diabetes in the multifaceted relationship between education and cognitive function.BMC Public Health. 2024 Sep 27;24(1):2584. doi: 10.1186/s12889-024-20156-x. BMC Public Health. 2024. PMID: 39334040 Free PMC article.
-
Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis.JMIRx Med. 2024 May 1;5:e55976. doi: 10.2196/55976. JMIRx Med. 2024. PMID: 38738836 Free PMC article.
-
Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.Cureus. 2024 Apr 12;16(4):e58115. doi: 10.7759/cureus.58115. eCollection 2024 Apr. Cureus. 2024. PMID: 38738005 Free PMC article.
-
Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status.J Am Heart Assoc. 2024 May 7;13(9):e034109. doi: 10.1161/JAHA.123.034109. Epub 2024 Apr 30. J Am Heart Assoc. 2024. PMID: 38686852 Free PMC article.
-
Comparison of Efficacy and Adherence of Patient-Preferred (1 Unit Daily) and ADA/EASD Guideline-Recommended (2 Units Every 3 Days) Basal Insulin Titration Algorithms: Multicenter, Randomized, Clinical Study.Patient Prefer Adherence. 2024 Mar 18;18:687-694. doi: 10.2147/PPA.S446855. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 38524199 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
